Location: Home
  • search
  • go
  • Relate News
  • 4/10/2025China Revises Military Drug Administration Measures to Strengthen Over...
  • 4/9/2025China Launches Phase I Trial for Nation's First Monkeypox Vaccine
  • 4/9/2025U.S. Urged to Boost Biotech Investment to Counter China's Strategic Ad...
  • 4/9/2025BioDuro Expands China Operations with New R&D and Manufacturing Campus...
  • 4/9/2025RemeGen Reports Positive Phase 3 Results for Telitacicept in gMG
  • 4/9/2025Chinese VMS OTC Market Growth Slowed to 2.7% in 2024
  • 4/9/2025Newish Tech Secures Series B Financing to Advance Next-Gen Cancer Vacc...
  • 4/8/2025Rigerna Thera Advances siRNA Drug Development with Pre-A Financing​
  • 4/8/2025TJ Biopharma, Biogen Enter Partnership to Advance Felzartamab in China
  • 4/8/2025Hengrui Grants Merck KGaA Exclusive Rights to SHR7280 in Mainland Chin...
  • 4/8/2025Beijing Unveils Ambitious Policy Package to Supercharge Biopharma Inno...
  • 4/8/2025Tariffs Spark Market Jitters, But China's Innovative Drug Sector Remai...
  • 4/8/2025Asia-Pacific Vaccine Market Set for Steady Growth Through 2035 Despite...
  • 4/8/2025Duality Bio Upsizes IPO Amid Global Market Challenges
  • 4/8/2025CDE Solicits Comments on Draft Q&A for CMC Issues in rAAV-Based In Vi...
  • 4/8/2025Akeso Initiates Investigator-Initiated Trial for Personalized mRNA Vac...
  • 4/8/2025China Approves Hansoh's Ibrexafungerp for Vaginal Yeast Infections
  • 4/8/2025NIH Ban Disrupts Some Chinese Genetics Research, But Broader Impact Se...
  • 4/7/2025NMPA Solicits Comments on the Announcement on Matters Related to the I...
  • 4/7/2025NMPA Mandates Digital QR Code System for Drug Manufacturing Licenses
  • 4/7/2025China Receives 2.6 Million ADR Reports in 2024, Severe Cases Make Up 1...
  • 4/7/2025Boehringer Ingelheim Highlights Long-Term Commitment to China, Focuses...
  • 4/5/2025BeiGene Terminates Development of Ociperlimab Following Unfavorable Tr...
  • 4/5/2025Hansoh Initiates Phase 1 Trial for ADC Drug HS-20122 Targeting Advance...
  • 4/5/2025Sanofi and Cathay Capital Launch CNY 2B Healthcare Innovation Fund in ...
  • 4/5/2025Novartis' Fabhalta (iptacopan) Approved in China for C3 Glomerulopathy
  • 4/5/2025China and WHO Collaborate on Quality Management Training to Boost Vacc...
  • 4/5/2025Global Pharma Leaders Engage with President Xi Amidst U.S.-China Trade...
  • 4/5/2025CASI Pharma Evaluates CEO's $40M Proposal for China Operations
  • 4/5/2025Recent Executive Moves
  • Page:12/771 Total number of articles:23109: [First][<<] [10] [11] [12] [13] [14] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group